REYKJAVIK, Iceland and TEL AVIV, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
CEO Leonard Schleifer reported "double-digit net sales growth for 3 of our leading products," highlighting a 26% increase in Dupixent, 24% for Libtayo at constant exchange rates, and a 10% increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback